Тёмный

Enzyme Inhibitors (Reversibility and Inhibition Mode) - Medicinal Chemistry 1.12 

Daniel S.
Подписаться 2 тыс.
Просмотров 4 тыс.
50% 1

Based on the reversibility, enzyme inhibitors can be categorized into irreversible and reversible inhibitors. Irreversible inhibitors would bind to the enzymes by forming much stronger interactions and “permanently” modify the enzyme. Reversible inhibitor binds to the enzymes by forming relatively weaker interactions or reversible covalent bond. When the inhibition is reversed, often times the enzyme could function again.
Based on the inhibition mechanism, enzyme inhibitors can be categorized into competitive, uncompetitive and non-competitive inhibitors. Competitive inhibitor would compete or prevent the binding of the substrate. Uncompetitive inhibitor would bind onto the enzyme-substrate complex that’s formed after the enzyme binds the substrate. While in noncompetitive inhibition, the binding of the inhibitor and the binding of the enzyme substrate are independent of each other. But in reality, the inhibition mode is often mixed, and the boundary is not as clear (mixed inhibition).
-About me-
I am a computational chemist in the pharmaceutical industry. I created the Mole Man Chem channel to explain some basic medicinal and biochemistry concepts because I believe the best way to relearn a concept is through teaching.
Feel free to email me with any questions at molemanchem@gmail.com
-Video lists-
Medicinal chemistry playlist: • What Is a Drug, Therap...
Drug discovery explained playlist: • What is the controvers...

Наука

Опубликовано:

 

6 авг 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии : 1   
@christapenman4240
@christapenman4240 Год назад
Thank you for such clear informative videos.
Далее
We Need to Rethink Exercise - The Workout Paradox
12:00
CYP450 Enzymes Drug Interactions MADE EASY in 5 MINS
5:17
КРАХ WINDOWS 19 ИЮЛЯ 2024 | ОБЪЯСНЯЕМ
10:04
How to Soldering wire in Factory ?
0:10
Просмотров 14 млн